05/08/2026
🩺 PSIM Multan Scientific Session | Academic Debate
The Pakistan Society of Internal Medicine (PSIM), in collaboration with the Pakistan Cardiac Society, Pakistan Hypertension League, and Highnoon Laboratories, proudly hosted an engaging academic debate titled:
"Dapagliflozin or Empagliflozin – A Billion Dollar Question!"
The session brought together renowned physicians, endocrinologists, cardiologists, and nephrologists to discuss the latest evidence, clinical outcomes, and practical approaches to the use of SGLT2 inhibitors in the management of diabetes, heart failure, and chronic kidney disease.
We were honored to have Prof. Dr. Javed Akram, Chairman Board of Directors, PSIM Pakistan, as the Chief Guest.
A sincere appreciation to:
Dr. Asim Munir Alvi – Speaker (Dapagliflozin)
Dr. Amir Bashir – Speaker (Empagliflozin)
Dr. Saba Khalid – Moderator
Our distinguished expert panel:
Prof. Dr. Kashif Ali Hashmi
Prof. Dr. Zahra Nazish
Prof. Dr. Arif Mahmood Bhatti
Prof. Dr. Ghulam Abbas
Program Organizer. Mr. Malik Arshad form Highnoon Laboratories
PSIM remains committed to promoting evidence-based medicine, continuous medical education, and meaningful scientific dialogue to improve patient care across Pakistan.